Of interest, Peluso et al. recently reported the generation of a human, anti-CD47 antibody, SRF231, which could induce both phagocytosis and cell death in vitro, in a number of xenograft models, and in tumor-bearing mice, leading to reduced tumor burden (Peluso et al. 2020). Here, CD47 is linked to neoplasm.